We further compared the frequency of CD11c+ B cells among HD, non-GO patients, and GO patients and found that CD11c+ B cells were significantly expanded in both non-GO and GO patients compared to HD (P<0.001) (Figure 1C). This evidence concerns the gene ITGAX and Huntington disease.